Press Releases :: Rigel Pharmaceuticals, Inc. (RIGL)

Feb 05, 2009 7:30am EST

Rigel to Present at BIO CEO & Investor Conference

Feb 03, 2009 6:00am EST

Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results

Feb 02, 2009 6:00pm EST

Rigel to Host Conference Call on February 3, 2009

Jan 23, 2009 7:30am EST

Rigel to Present at Keystone Symposia Conference

Dec 08, 2008 7:30am EST

Rigel to Participate at the RBC Capital Markets Healthcare Conference

Dec 03, 2008 7:30am EST

Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH

Nov 25, 2008 7:30am EST

Rigel to Present at the Piper Jaffray Annual Health Care Conference

Nov 11, 2008 7:30am EST

Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism

Nov 11, 2008 7:00am EST

Rigel to Present at the 2008 Credit Suisse Healthcare Conference

Nov 03, 2008 3:00am EST

Rigel Announces Third Quarter 2008 Financial Results and Clinical Update

Previous
1…
31
32
33
34
35
36
37
38
39
40
Next